---
title: "Entera Bio appoints Geno J. Germano as Chairman with Pfizer experience, advancing programs towards 2026 milestones."
description: "Entera welcomes a new chairman to their board, bringing extensive global leadership experience from prominent biopharma companies like Pfizer and Wyeth. The new addition signals Entera's progression a"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276012286.md"
published_at: "2026-02-15T19:48:38.000Z"
---

# Entera Bio appoints Geno J. Germano as Chairman with Pfizer experience, advancing programs towards 2026 milestones.

> Entera welcomes a new chairman to their board, bringing extensive global leadership experience from prominent biopharma companies like Pfizer and Wyeth. The new addition signals Entera's progression as they work towards achieving significant milestones in 2026 with multiple oral peptide programs. This development marks a pivotal moment for Entera as they strive to drive innovation and growth in the biopharmaceutical industry, leveraging the expertise and insights of their new chairman to propel their initiatives forward.

Entera welcomes a new chairman to their board, bringing extensive global leadership experience from prominent biopharma companies like Pfizer and Wyeth. The new addition signals Entera's progression as they work towards achieving significant milestones in 2026 with multiple oral peptide programs. This development marks a pivotal moment for Entera as they strive to drive innovation and growth in the biopharmaceutical industry, leveraging the expertise and insights of their new chairman to propel their initiatives forward.

### Related Stocks

- [IBBQ.US - Invesco Nasdaq Biotechnology ETF](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US - Proshares Ultra Nasdaq Biotech](https://longbridge.com/en/quote/BIB.US.md)
- [VHT.US - VG Health](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US - First Trust NYSE Arca Biotech Index Fd](https://longbridge.com/en/quote/FBT.US.md)
- [IHE.US - iShares US Pharma](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US - Invesco Biotechnology & Genome ETF](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US - SPDR S&P Biotech](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US - VanEck Biotech ETF](https://longbridge.com/en/quote/BBH.US.md)
- [ENTX.US - Entera Bio](https://longbridge.com/en/quote/ENTX.US.md)
- [IBB.US - iShares Biotechnology ETF](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Basilea Pharmaceutica erhält Meilensteinzahlung für Cresemba-Verkäufe in Asien und China | Basilea Pharmaceutica AG announced a milestone payment of $5 million triggered by strong sales of its antifungal drug Cr | [Link](https://longbridge.com/en/news/275271671.md) |
| Bio-Works Technologies AB Receives 11 MSEK Order from Returning Biopharma Customer | Bio-Works Technologies AB has secured an 11 million SEK order from a returning biopharma customer for chromatography pro | [Link](https://longbridge.com/en/news/276129486.md) |
| 07:59 ETPfizer Becomes Newest Partner Added to BaseLaunch's Biotech Venture Incubator | BaseLaunch has announced that Pfizer is the newest partner in its biotech venture incubator, increasing the total number | [Link](https://longbridge.com/en/news/275461886.md) |
| Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund | Pfizer has agreed to accept $29 million to settle a dispute with the SEC related to an insider trading case involving St | [Link](https://longbridge.com/en/news/275506783.md) |
| AnaptysBio Details Q2 Royalty Spin, Jemperli Growth and ANB033 Celiac Data Coming in Q4 | AnaptysBio (NASDAQ:ANAB) plans to separate its royalty business from its clinical-stage biopharma operations, targeting  | [Link](https://longbridge.com/en/news/275802733.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.